|
|
OmniComm’s experience in Phase II/III continues to grow, adding to an already robust portfolio of executed studies. While our software allows for complex data capture, our ability to handle large volumes of data and concurrent transactions, set us apart from many other EDC vendors. This is critical for large/Phase III studies. Our data center rivals that of the largest sponsors and our technology has been proven both through testing and real-world execution. Our people however, are what set us apart. From our industry-experienced leadership, to our project management, to our clinical experts, OmniComm ensures clinical trial success by using people that understand clinical research. Finally, change is an ongoing aspect of clinical trials. How we manage change is one of the things that also distinguish us and makes our experience in Phase II/III beneficial to you. From having built-in software functions to how we handle mid-study changes and numbers of sites, OmniComm can help. Furthermore, we establish controls at the beginning of the study to manage costs, such that change orders are minimized or avoided all-together. If you would like to learn more, please contact Bev Hudson bhudson@omnicomm.com |